Proteinuria Following a Switch from Calcineurin Inhibitors to Sirolimus
- 1 November 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 80 (9) , 1198-1203
Abstract
Background. Sirolimus is an alternative option for kidney transplant patients treated with calcineurin inhibitors (CNI) when renal function is deteriorating. However, the incidence of proteinuria following a switch from CNI to sirolimus has caused concern, and was therefore investigated here. Methods. In a retrospective study, 68 renal transplant recipients were switched from CNI to sirolimus. Proteinuria was measured using 24-hour urine collection before the switch and collections 3, 6, 12, and 24 months thereafter. In addition, proteinuria was measured in patients who had to be switched back to CNI due to side effects. Survival analyses were performed. Results. Baseline proteinuria was 0.39±0.69 g/day in all 68 patients. It increased to a mean 1.44±1.90 g/day at 3 months (PP<0.05). Proteinuria above 0.3 g/day before the CNI-sirolimus switch correlated significantly with the decrease of renal function thereafter. Conclusion. CNI-treated kidney transplant recipients may develop reversible proteinuria when switched to sirolimus.Keywords
This publication has 23 references indexed in Scilit:
- An open‐label, pilot study evaluating the safety and efficacy of converting from calcineurin inhibitors to sirolimus in established renal allograft recipients with moderate renal insufficiencyClinical Transplantation, 2004
- Long-Term Benefits with Sirolimus-Based Therapy after Early Cyclosporine WithdrawalJournal of the American Society of Nephrology, 2004
- The Natural History of Chronic Allograft NephropathyNew England Journal of Medicine, 2003
- The Renal Arterial Resistance Index and Renal Allograft SurvivalNew England Journal of Medicine, 2003
- Sirolimus therapy without calcineurin inhibitors: Necker Hospital 8-year experienceTransplantation Proceedings, 2003
- Post-transplant renal function in the first year predicts long-term kidney transplant survivalKidney International, 2002
- Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre studyThe Lancet, 2000
- Association of chronic kidney graft failure with recipient blood pressureKidney International, 1998
- MULTICENTER RANDOMIZED TRIAL COMPARING TACROLIMUS (FK506) AND CYCLOSPORINE IN THE PREVENTION OF RENAL ALLOGRAFT REJECTION1Transplantation, 1997
- Chronic cyclosporine nephropathy: The Achilles' heel of immunosuppressive therapyKidney International, 1996